Covid


NEWS & OPINION

Over 50% in 15-18 years age group have received 1st dose of Covid-19 vaccine
Over 50% in 15-18 years age group have received 1st dose of Covid-19 vaccine

Those in the 15-18 years age group began receiving Covid-19 vaccines from January 3 this year

India tackling another wave of pandemic with caution and confidence: PM Modi
India tackling another wave of pandemic with caution and confidence: PM Modi

India's strength is an example for the whole world at the moment, PM Narendra Modi said at the WEF's Davos Agenda summit

Over 156 crore doses administered as India completes 1 year of Covid-19 vaccination campaign
Over 156 crore doses administered as India completes 1 year of Covid-19 vaccination campaign

PM Narendra Modi lauded the efforts of those associated with the Covid-19 vaccination drive

Stay alert but ensure there is no panic: PM Modi on Covid-19 situation
Stay alert but ensure there is no panic: PM Modi on Covid-19 situation

Vaccination remains the proven way to tackle Covid-19 irrespective of the variant, PM Modi said

PM Modi calls for active surveillance and technical support to states with higher Covid cases
PM Modi calls for active surveillance and technical support to states with higher Covid cases

In the last 24 hours, India has reported 1,59,632 new positive cases

India crosses 1.5 billion Covid-19 vaccination doses landmark
India crosses 1.5 billion Covid-19 vaccination doses landmark

More than 90% of India's adults have now received the first dose of the vaccine

Over 150 crore Covid-19 vaccine doses provided to states, UTs: Health Ministry
Over 150 crore Covid-19 vaccine doses provided to states, UTs: Health Ministry

More than 19.52 crore balance and unutilized vaccine doses are still available with the States/UTs

India ready to fight Covid-19 with 8 vaccines, wider vaccination coverage
India ready to fight Covid-19 with 8 vaccines, wider vaccination coverage

Earlier this week, two more Covid vaccines and antiviral drug Molnupiravir were cleared for use

‘Satark, Saavdhan’: PM Modi's words during review of Covid-19, Omicron
‘Satark, Saavdhan’: PM Modi's words during review of Covid-19, Omicron

Prime Minister Modi stressed on continued adherence to COVID safe behaviour

Covid-19 Update: India's vaccination coverage crosses 132-crore dose mark
Covid-19 Update: India's vaccination coverage crosses 132-crore dose mark

India’s recovery rate stands at 98.36%, the highest since March 2020

Covid-19 vaccination: 50% of India's eligible population now fully vaccinated with two doses
Covid-19 vaccination: 50% of India's eligible population now fully vaccinated with two doses

Over 482 million people have received both doses of the Covid-19 vaccine

Severity of disease due to Covid-19 variant Omicron anticipated to be low: Health Ministry
Severity of disease due to Covid-19 variant Omicron anticipated to be low: Health Ministry

The Omicron variant is likely to spread to more countries including India, the ministry said

India’s Covid-19 vaccination coverage crosses 126.53 crore doses
India’s Covid-19 vaccination coverage crosses 126.53 crore doses

8,603 new cases were reported in the last 24 hours

Amid Omicron fears, DGCA postpones resumption of international flights in India
Amid Omicron fears, DGCA postpones resumption of international flights in India

It had earlier announced that scheduled international flights would resume operations from December 15

Covishield vaccine remained effective against COVID-19 during April-May surge: Study
Covishield vaccine remained effective against COVID-19 during April-May surge: Study

According to the Lancet, Covishield’s vaccine efficacy was determined to be 63% in completely vaccinated persons

Covid-19 update: Union Health Ministry issues revised guidelines for international travelers
Covid-19 update: Union Health Ministry issues revised guidelines for international travelers

The new guidelines shall come into effect on December 1 at 00.01 Hours

Bharat Biotech resumes export of COVAXIN
Bharat Biotech resumes export of COVAXIN

On November 3, the World Health Organisation had issued an emergency use listing for COVAXIN

Home Secretary chairs urgent meeting on new COVID variant of concern ‘Omicron’
Home Secretary chairs urgent meeting on new COVID variant of concern ‘Omicron’

SOPs on testing and surveillance of incoming international passengers will be reviewed

PM Modi reviews vaccination related situation across India
PM Modi reviews vaccination related situation across India

The meeting was chaired by PM Modi to review the country’s preparedness in view of threat posed by a new variant of the Covid-19

Covid-19 update: India’s cumulative vaccination coverage crosses 1.2 billion mark
Covid-19 update: India’s cumulative vaccination coverage crosses 1.2 billion mark

The country reported 10,549 new cases in the last 24 hours

Stories from 31 May 2020 to 13th March 2020

Disinformation

Claims of under-reporting of COVID-19 deaths are ill-informed, baseless & misleading: Health Ministry
Claims of under-reporting of COVID-19 deaths are ill-informed, baseless & misleading: Health Ministry

The reports are based on a study which seems biased in nature, the ministry said

No, Indians are not letting their guard down in the battle against Covid-19
No, Indians are not letting their guard down in the battle against Covid-19

An article in the New York Times tries to create a misleading narrative that Indians have stopped wearing masks

Clearing misconceptions & misinformation around the use of Covaxin
Clearing misconceptions & misinformation around the use of Covaxin

Approvals by the national regulator are based on comprehensive analysis and examination of data

Govt terms reports claiming India missed Covid-19 vaccination targets as ‘misleading’
Govt terms reports claiming India missed Covid-19 vaccination targets as ‘misleading’

India has administered more 1st doses of COVID-19 vaccines than the US, UK, France and Spain

Foreign Media

Three COVID-19 vaccines at clinical trial stage, two have completed phase 1 trial in India: ICMR DG
Three COVID-19 vaccines at clinical trial stage, two have completed phase 1 trial in India: ICMR DG

Serum Institute of India (SII) has completed phase II-B3 trials and will start phase-III trial after clearances

ثلاثة لقاحات COVID-19 في مرحلة التجارب السريرية ، أكمل اثنان المرحلة الأولى من التجربة في الهند: ICMR DG
ثلاثة لقاحات COVID-19 في مرحلة التجارب السريرية ، أكمل اثنان المرحلة الأولى من التجربة في الهند: ICMR DG

أكمل معهد مصل الهند (SII) تجارب المرحلة II-B3 وسيبدأ تجربة المرحلة الثالثة بعد التصاريح

ক্লিনিকাল ট্রায়াল পর্যায়ে তিনটি COVID-19 টি ভ্যাকসিন, দুটি ভারতে প্রথম পর্যায়ের ট্রায়াল সম্পন্ন করেছে: আইসিএমআর ডিজি
ক্লিনিকাল ট্রায়াল পর্যায়ে তিনটি COVID-19 টি ভ্যাকসিন, দুটি ভারতে প্রথম পর্যায়ের ট্রায়াল সম্পন্ন করেছে: আইসিএমআর ডিজি

সেরাম ইনস্টিটিউট অফ ইন্ডিয়া (এসআইআই) দ্বিতীয় ধাপে-বি 3 ট্রায়াল সম্পন্ন করেছে এবং ছাড়পত্রের পরে দ্বিতীয় ধাপের তৃতীয় বিচার শুরু করবে

Drei COVID-19-Impfstoffe in der klinischen Studienphase, zwei haben die Phase-1-Studie in Indien abgeschlossen: ICMR DG
Drei COVID-19-Impfstoffe in der klinischen Studienphase, zwei haben die Phase-1-Studie in Indien abgeschlossen: ICMR DG

Das Serum Institute of India (SII) hat die Phase-II-B3-Studien abgeschlossen und wird nach Freigabe mit der Phase-III-Studie beginnen